Public Health Alerts#

  • Measles update October 23, 2025

    To: Ottawa Physicians and Nurse Practitioners  
    Date: October 23, 2025
    From: Dr. Michelle Foote, Associate Medical Officer of Health
    Subject: Measles update October 23, 2025

    Dear Colleagues,

    Ottawa Public Health (OPH) has recently confirmed five measles infections among related individuals.

  • Information for the 2025/2026 COVID-19 Vaccine Program and Universal Influenza Immunization Program

    To: Ottawa Physicians and Nurse Practitioners
    Date: September 25, 2025
    From:  Dr. Laura Bourns, Deputy Medical Officer of Health
    Subject: Information for the 2025/2026 COVID-19 Vaccine Program and Universal Influenza Immunization Program 

    Dear Colleagues,

    This communication provides details on the 2025-2026 Universal Influenza Immunization Program (UIIP) and COVID-19 vaccine program.

  • Rocky Mountain Spotted Fever Exposures at Long Point, ON

    To: Ottawa Physicians and Nurse Practitioners
    Date: September 22, 2025
    From: Dr. Emil Prikryl, Associate Medical Officer of Health
    Subject: Rocky Mountain Spotted Fever Exposures at Long Point, ON

    Dear Colleagues,

    Please see linked below a memo from Ontario’s Office of the Chief Medical Officer of Health regarding Rocky Mountain Spotted Fever (RMSF) exposures at Long Point, Ontario.

  • Product ordering information for Ontario’s RSV prevention programs

    To: Ottawa Physicians, Nurse Practitioners, and Midwives
    Date: September 18, 2025
    From:  Dr. Laura Bourns, Deputy Medical Officer of Health
    Subject: Product ordering information for Ontario’s RSV prevention programs

    Dear Colleagues,

    In follow-up to the Public Health Alert shared September 15, 2025 ‘

  • Increased Incidence of Anaplasmosis in Ontario, 2025

    To: Ottawa Physicians and Nurse Practitioners
    Date: September 16, 2025
    From: Dr. Emil Prikryl, Associate Medical Officer of Health
    Subject: Increased Incidence of Anaplasmosis in Ontario, 2025

    Dear Colleagues,

    A recent report of a death in an Ottawa resident caused by anaplasmosis serves as a reminder that we remain very much in the season for tick-borne diseases such as

  • Information on Ontario's RSV Prevention Programs

    To: Ottawa Physicians, Nurse Practitioners, and Midwives
    Date: September 15, 2025
    From: Dr. Laura Bourns, Deputy Medical Officer of Health
    Subject: Information on Ontario’s RSV prevention programs

    Dear Colleagues,

    The below communication provides information on Respiratory Syncytial Virus (RSV) prevention programs the 2025-2026 RSV season for:

    1. high-risk older adults, and
    2. infants and high-risk children

    Please note: The RSV product order forms will be available at

  • Discontinuation of Provincial COVID-19 Test Results Viewer

    To: Ottawa Physicians
    Date: September 2, 2025
    From: Dr. Laura Bourns, Deputy Medical Officer of Health
    Subject: Discontinuation of Provincial COVID-19 Test Results Viewer

    Dear Colleagues,

    Please see below a memo from Ontario’s Chief Medical Officer of Health regarding the discontinuation of the provincial COVID-19 Test Results Viewer.

  • Market Withdrawal of COVID-19 KP.2 vaccines

    To: Ottawa Physicians
    Date: August 29, 2025
    From: Dr. Laura Bourns, Deputy Medical Officer of Health
    Subject: Market Withdrawal of COVID-19 KP.

  • First Ottawa human case of West Nile Virus in 2025

    To: Ottawa Physicians and Nurse Practitioners
    Date: Aug 27, 2025
    From: Dr. Robin Taylor, Associate Medical Officer of Health

    Dear Colleagues,

    Ottawa Public Health (OPH) is writing to heighten your awareness of the possibility of illness from West Nile virus (WNV) infection in Ottawa, as the first human case of WNV has been reported in an Ottawa resident for the 2025 season.

  • Updated PHO AEFI Reporting Form

    To: Ottawa Physicians and Nurse Practitioners 
    Date: August 20, 2025
    From: Dr. Laura Bourns, Deputy Medical Officer of Health
    Subject: Updated PHO AEFI Reporting Form

    Dear Colleagues,

    In Ontario, Public Health Ontario (PHO) leads the provincial surveillance of adverse events following immunization (AEFIs).

Welcome to the new OttawaPublicHealth.ca

Ottawa Public Health has moved to a refreshed website. During this transition, some links, redirects, documents, pages or display features may be temporarily affected.

Your feedback will help us review and address issues during the stabilization period.